Skip to content
PMX Solutions
Menu
  • Home
  • Applications
    • PK profile over time
    • Therapeutic window
    • Therapeutic window + IIV
    • PK simulations and reporting
  • Tutorials
    • Abbreviations
    • Visual predictive checks
    • R Related
    • Shiny Application
  • About
  • GitHub code for Shiny apps

Author: MJvanEsdonk

Personal blog / Tutorials

From Animals to Algorithms: Leveraging PK/PD Models to Drive the 3R’s in Pharmacology

In the pursuit of ethical and efficient drug development, the scientific community continues to embrace the 3R’s principle — Replacement, Reduction, and Refinement — to minimize the use of animals …

Tutorials

Exploration of intra-individual variability in a multiple dose study during NCA

A non-compartmental analysis (NCA) is commonly performed to analyse the data of a pharmacokinetic study. It is an easy way of getting your pharmacokinetic parameters (such as the Cmax, tmax, …

Personal blog

A pharmacometrician’s job interview: the case study

In 2022 I was working as a senior pharmacometrician (primarily focused on clinical phase 1/2a PK/PD and scientific research) when I was contacted by a recruiter on LinkedIn to apply …

Personal blog

Learn about pharmacometrics and clinical pharmacology during your workout

I love to listen to podcasts while I am working out or going for a walk. However, I must admit that some of these podcasts are just a background conversation …

Personal blog / Tutorials

Exploring the Capabilities of ChatGPT: A Step-by-Step Guide to Creating a Pharmacokinetic Analysis Shiny App

With the introduction of ChatGPT I was interested to learn how ChatGPT in pharmacometrics might be applied and how this will impact my code writing tasks, especially for doing pharmacokinetic …

Software

Using R Shiny applications in scientific research – Can you spot a drug effect on blinded pharmacodynamic data…?

Shiny applications are commonly used as a data dashboard, to automate a (data science) workflow, or to easily build a minimum viable product. Shiny is a great tool if you …

Personal blog

Introduction to pharmacometrics and its importance in drug development

Pharmacometrics is a rapidly growing field that combines pharmacology, mathematics, and statistics to optimize drug development and dosing. It is the science of quantifying drug effects in patients and developing …

Software

New shiny applications for PMX simulations!

A range of new shiny applications have been published on this website to visualise pharmacokinetic profiles over time and better understand the use of population models. All applications can be …

Personal blog

Abbreviations and Terminology Used in Population Pharmacokinetics/Pharmacodynamic Models and in Pharmacometrics

This page provides an overview of the abbreviations and terminology commonly used in population PK/PD articles.

Personal blog

Publishing the covariance matrix of population models. Why not?

The information in the covariance matrix Everyone that has worked for longer than a day with NONMEM has a high probability of encountering error messages mentioning the covariance matrix (nonpositive …

Posts navigation

Older posts

Recent posts:

  • From Animals to Algorithms: Leveraging PK/PD Models to Drive the 3R’s in Pharmacology
  • Exploration of intra-individual variability in a multiple dose study during NCA
  • A pharmacometrician’s job interview: the case study
  • Learn about pharmacometrics and clinical pharmacology during your workout
  • Exploring the Capabilities of ChatGPT: A Step-by-Step Guide to Creating a Pharmacokinetic Analysis Shiny App
  • Using R Shiny applications in scientific research – Can you spot a drug effect on blinded pharmacodynamic data…?
  • Introduction to pharmacometrics and its importance in drug development
  • New shiny applications for PMX simulations!
  • Abbreviations and Terminology Used in Population Pharmacokinetics/Pharmacodynamic Models and in Pharmacometrics
  • Publishing the covariance matrix of population models. Why not?
Copyright © 2025 PMX Solutions – part of Axiaal Data Analytics – Disclaimer – Privacy and cookie statement